Clinical highlights of the national institute of diabetes and digestive and kidney diseases/interstitial cystitis association scientific conference on interstitial cystitis

Urology

Volumn 57, Issue 6, 2001, Pages 2-6

  Hanno, Philip M ^a   Sant, Grannum R ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; HEALTH CARE ORGANIZATION; HUMAN; INTERSTITIAL CYSTITIS; MEDICAL SOCIETY; PELVIS PAIN SYNDROME; UNITED STATES;

CYSTITIS, INTERSTITIAL; HUMANS; MINNESOTA; NATIONAL INSTITUTES OF HEALTH (U.S.); PELVIC PAIN; SOCIETIES, MEDICAL; UNITED STATES;

EID: 0035383131     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01112-8     Document Type: Article

References (31)

1. Steers WD: Interstitial cystitis: past and future [abstract]. Urology 57(suppl 6A): 101, 2001.
2. Wesselmann U: Interstitial cystitis: a chronic visceral pain syndrome. Urology 57(suppl 6A): 32-39, 2001.
3. Rothrock NE, Lutgendorf SK, Kreder KJ, et al: Daily stress and symptom exacerbation in interstitial cystitis patients [abstract]. Urology 57: 122, 2001.
4. Peeker R, Aldenborg F, Dahlstrom A, et al: Immunological and neurobiologic characteristics support that IC is a heterogeneous syndrome [abstract]. Urology 57(suppl 6A): 130, 2001.
5. Fall M, Aldenborg F, Johansson S, et al: Clinical characteristics support that IC is a heterogeneous syndrome [abstract]. Urology 57(suppl 6A): 129, 2001.
6. Forrest J, and Vo Q: Observations on the presentation, diagnosis, and management of interstitial cystitis in men. Urology 57(suppl 6A): 26-29, 2001.
7. Indudhara R, Kubricht W, and Lloyd K: Interstitial cystitis in males [abstract]. Urology 57: 120, 2001.
8. Schuster GA: Interstitial cystitis in children: not a rare entity [abstract]. Urology 57(suppl 6A): 107, 2001.
9. Mishra N: Interstitial cystitis in India: Important lessons [abstract]. Urology 57(suppl 6A): 107, 2001.
10. Warren J, Jackson T, Meyers D, et al: Concordance of interstitial cystitis between identical twins: preliminary data [abstract]. Urology 57(suppl 6A): 126, 2001.
11. Stoney C, Bonfiglio D, Buffington T, et al: Symptom reports among interstitial cystitis patients [abstract]. Urology 57(suppl 6A): 127, 2001.
12. Gershbaum D and Moldwin R: Practice trends for the management of interstitial cystitis [abstract]. Urology 57(suppl 6A): 119, 2001.
13. Keay SK, Zhang C-O, Shoenfelt J, et al: Sensitivity and specificity of antiproliferative factor (APF), heparin-binding epidermal growth factor (HB-EGF), and epidermal growth factor (EGF)-as urine markers for interstitial cystitis. Urology 57(suppl 6A): 9-14, 2001.
14. Parsons CL, Stein PC, Bidair M, et al: Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn 13: 515-520, 1994.
15. Payne CK, Sirinian E, and Azevedo K: The effect of physiologic levels of urinary potassium on interstitial cystitis symptoms [abstract]. Urology 57(suppl 6A): 124, 2001.
16. Sirinian E, and Payne CK: Correlation of symptoms between 2 instruments among interstitial cystitis patients [abstract]. Urology 57(suppl 6A): 124, 2001.
17. Mortensen S, NordlingJ, Horn T, et al: Interstitial cystitis: a proposal on cardinal symptoms and signs [abstract]. Urology 57(suppl 6A): 122, 2001.
18. Hanus T, Zámecník L, Jansky M, et al: The comparison of clinical and histopathologic features of interstitial cystitis [abstract]. Urology 57(suppl 6A): 131, 2001.
19. 4 receptor antagonist [abstract]. Urology 57(suppl 6A): 118, 2001.
20. Dimitrakov J, Tchitalov J, Zlatanov T, et al: Recombinant human nerve growth factor in the treatment of interstitial cystitis: preliminary results [abstract]. Urology 57(suppl 6A): 118, 2001.
21. Bologna RA, Gomelsky A, Lukban JC, et al: The efficacy of calcium glycerophosphate in the prevention of food-related flares in interstitial cystitis [abstract]. Urology 57(suppl 6A): 119, 2001.
22. Nickel JC, Forrest J, Barkin J, et al: Safety and efficacy of up to 900 mg/day pentosan polysulfate sodium (Elmiron) in patients with interstitial cystitis [abstract]. Urology 57(suppl 6A): 122, 2001.
23. Lewi H: Medical therapy in interstitial cystitis: the Essex experience [abstract]. Urology 57(suppl 6A): 120, 2001.
24. Chancellor MB: RTX Exotoxins [abstract]. Urology 57(suppl 6A): 105, 2001.
25. Lazzeri M, and Beneforti P, et al: Single dose of resiniferatoxin for the treatment of interstitial cystitis: preliminary results of a randomized controlled study [abstract]. J Urol 163S: 60, 2000.
26. Henry, RA, Patterson L, Nickel C, et al: Alkalinized intravesical lidocaine to treat interstitial cystitis: absorption kinetics in normal and interstitial cystitis bladders [abstract]. Urology 57(suppl 6A): 119, 2001.
27. Nordling J, Jørgensen S, and Kallestrup E: Cystistat for the treatment of interstitial cystitis: a 3-year follow-up study [abstract]. Urology 57(suppl 6A): 123, 2001.
28. Holzberg A, Kellog-Spadt S, Lukban J, et al: The evaluation of transvaginal Theile massage as a therapeutic intervention for women with IC [abstract]. Urology 57(suppl 6A): 120, 2001.
29. Lukban J, Whitmore K, Kelllog-Spadt S, et al: The effect of manual physical therapy in patients diagnosed with interstitial cystitis, high-tone pelvic floor dysfunction, and sacroiliac dysfunction [abstract]. Urology 57(suppl 6A): 121, 2001.
30. Caraballo R, Bologna RA, Lukban J, et al: Sacral nerve stimulation as a treatment for urge incontinence and associated pelvic floor disorders at a pelvic floor center: a follow-up study [abstract]. Urology 57(suppl 6A): 121, 2001.
31. Paszkiewicz EJ, Siegel SW, Kirkpatrick C, et al: Sacral nerve stimulation in patients with chronic intractable pelvic pain [abstract]. Urology 57(suppl 6A): 124, 2001.